RSJ Gradus focuses on investments in the area of Life Sciences; mainly research aimed at improving and prolonging human life. The sub-fund of RSJ invests into newly or recently established technology companies and actively seeks out startups with revolutionary therapeutic methods. Main emphasis is on areas that current health-care approaches failed to sufficiently resolve.
RSJ Gradus invests exclusively into areas where we have deep knowledge available and which lie on the margins of interest of for traditional risk-capital funds (venture funds). We are long-term investors, who closely collaborate with management of the companies in which we invest. We prefer the role of a lead investor in our projects.
Potential for future sale of the company.
Clearly defined clinical goals, possibly in synergy with other companies within the portfolio.
Focus on USA and EU.
RSJ Gradus is a sub-fund of the investment fund RSJ Investments SICAV a.s.